The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep

Vaccine

Volumn 27, Issue 1, 2009, Pages 45-50

  Hacariz O ^a   Sayers, G ^a   McCullough, M ^a   Garrett, M ^a   O'Donovan, J ^a   Mulcahy, G ^a  

^a School of Biology and Environmental Science   (Ireland)

Author keywords

Adjuvant; Antibody; Fasciola hepatica; Quil A; Th1

Indexed keywords

ADJUVANT; FREUND ADJUVANT; GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE DEHYDROGENASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; PARASITE ANTIGEN; PHOSPHATE BUFFERED SALINE; PLASMA PROTEIN; QUIL A; TITERMAX GOLD; TITERMAX GOLD ADJUVANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOPSY; BLOOD CHEMISTRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; FASCIOLA HEPATICA; FASCIOLIASIS; FECES ANALYSIS; HEMATOLOGY; IMMUNOGENICITY; LIVER HOMOGENATE; METACERCARIA; NONHUMAN; PRIORITY JOURNAL; SHEEP DISEASE; TH1 CELL; WEIGHT GAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; FASCIOLA HEPATICA; FASCIOLIASIS; FECES; PARASITE EGG COUNT; RANDOM ALLOCATION; SAPONINS; SHEEP; SHEEP DISEASES; TIME FACTORS; WEIGHT GAIN;

EID: 56949083591     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.035     Document Type: Article

References (37)

1. O'Neill S.M., Parkinson M., Strauss W., Angles R., and Dalton J.P. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am J Trop Med Hyg 58 4 (1998) 417-423
2. Mas-Coma S., Bargues M.D., and Esteban J.G. Human fasciolosis. In: Dalton J.P. (Ed). Fasciolosis (1999), CAB International, Wallingford, UK 411-434
3. Dalton J.P., and Mulcahy G. Parasite vaccines-a reality?. Vet Parasitol 98 1-3 (2001) 149-167
4. Dalton J.P., McGonigle S., Rolph T.P., and Andrews S.J. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect Immun 64 12 (1996) 5066-5074
5. Mulcahy G., O'Connor F., Clery D., Hogan S.F., Dowd A.J., Andrews S.J., et al. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines. Res Vet Sci 67 1 (1999) 27-33
6. Muro A., Ramajo V., López J., Simón F., and Hillyer G.V. Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins. Vet Parasitol 69 3-4 (1997) 219-229
7. Sexton J.L., Milner A.R., Panaccio M., Waddington J., Wijffels G., Chandler D., et al. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep. J Immunol 145 11 (1990) 3905-3910
8. Morrison C.A., Colin T., Sexton J.L., Bowen F., Wicker J., Friedel T., et al. Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine 14 17-18 (1996) 1603-1612
9. Spithill T.W., Smooker P.M., Sexton J.L., Bozas E., Morrison C.A., Creany J., et al. Development of vaccines against Fasciola hepatica. In: Dalton J.P. (Ed). Fasciolosis (1999), CAB International, Wallingford, UK 377-410
10. Kenney J.S., Hughes B.W., Masada M.P., and Allison A.C. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods 121 2 (1989) 157-166
11. Marciani D.J. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today 8 20 (2003) 934-943
12. Baldridge J.R., Yorgensen Y., Ward J.R., and Ulrich J.T. Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration. Vaccine 18 22 (2000) 2416-2425
13. Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 5 7 (2007) 505-517
14. Dalsgaard K. Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines. Arch Gesamte Virusforsch 44 3 (1974) 243-254
15. Kensil C.R. Saponins as vaccine adjuvants. Crit Rev Ther Drug Carrier Syst 13 1-2 (1996) 1-55
16. Newman M.J., Wu J.Y., Gardner B.H., Munroe K.J., Leombruno D., Recchia J., et al. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J Immunol 148 8 (1992) 2357-2362
17. Behboudi S., Morein B., and Villacres-Eriksson M.C. Quillaja saponin formulations that stimulate proinflammatory cytokines elicit a potent acquired cell-mediated immunity. Scand J Immunol 50 4 (1999) 371-377
18. Kensil C.R., Patel U., Lennick M., and Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol 146 2 (1991) 431-437
19. Lightowlers M.W., Waterkeyn J.G., Rothel J.S., Gauci C.G., and Harrison G.B. Host-protective fragments and antibody binding epitopes of the Taenia ovis 45W recombinant antigen. Parasite Immunol 18 10 (1996) 507-513
20. Lightowlers M.W. Cestode vaccines: origins, current status and future prospects. Parasitology 133 Suppl. (2006) S27-S42
21. Freund J. The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review. Am J Clin Pathol 21 7 (1951) 645-656
22. Aguilar J.C., and Rodríguez E.G. Vaccine adjuvants revisited. Vaccine 25 19 (2007) 3752-3762
23. Broderson J.R. A retrospective review of lesions associated with the use of Freund's adjuvant. Lab Anim Sci 39 5 (1989) 400-405
24. Jennings V.M. Review of selected adjuvants used in antibody production. ILAR J 37 3 (1995) 119-125
25. Stills Jr. H.F. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J 46 3 (2005) 280-293
26. Clery D., Torgerson P., and Mulcahy G. Immune responses of chronically infected adult cattle to Fasciola hepatica. Vet Parasitol 62 1-2 (1996) 71-82
27. Urquhart G.M., Armour J., Duncan J.L., Dunn A.M., and Jennings F.W. Veterinary parasitology. 2nd ed. (1996), Blackwell Science Ltd., Scotland
28. Kooyman F.N., Van Kooten P.J., Huntley J.F., MacKellar A., Cornelissen A.W., and Schallig H.D. Production of a monoclonal antibody specific for ovine immunoglobulin E and its application to monitor serum IgE responses to Haemonchus contortus infection. Parasitology 114 Pt 4 (1997) 395-406
29. Mulcahy G., O'Connor F., McGonigle S., Dowd A., Clery D.G., Andrews S.J., et al. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine 16 9-10 (1998) 932-939
30. Chavali S.R., Francis T., and Campbell J.B. An in vitro study of immunomodulatory effects of some saponins. Int J Immunopharmacol 9 6 (1987) 675-683
31. Petrovsky N. Freeing vaccine adjuvants from dangerous immunological dogma. Expert Rev Vaccines 7 1 (2008) 7-10
32. Anderson C.C., and Matzinger P. Danger: the view from the bottom of the cliff. Semin Immunol 12 3 (2000) 231-238
33. Fernando G.J., Stewart T.J., Tindle R.W., and Frazer I.H. Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term. Scand J Immunol 47 5 (1998) 459-465
34. Weeratna R.D., McCluskie M.J., Xu Y., and Davis H.L. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 18 17 (2000) 1755-1762
35. O'Neill S.M., Brady M.T., Callanan J.J., Mulcahy G., Joyce P., Mills K.H., et al. Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol 22 3 (2000) 147-155
36. Donnelly S., O'Neill S.M., Sekiya M., Mulcahy G., and Dalton J.P. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect Immun 73 1 (2005) 166-173
37. Flynn R.J., Irwin J.A., Olivier M., Sekiya M., Dalton J.P., and Mulcahy G. Alternative activation of ruminant macrophages by Fasciola hepatica. Vet Immunol Immunopathol 120 1-2 (2007) 31-40